Report me for selling fake medicine? Why are you crying when your illness relapses?

Chen Xuan was just stating a fact, but this fact overturned everyone's cognition and made them feel it was unrealistic.

But now, they no longer think so, but are very sure that it has this value.

At this moment, Mo Xuefeng was even considering whether to include the lung cancer specific drug as the first choice drug for treating hepatitis B?

Of course, it was impossible for him to make the final decision on such an important matter alone.

Everything still needs to be discussed in a meeting, and there must be sufficient data to support it.

But this idea has taken root in his heart and will come true sooner or later.

"$1000 million."

"Sure enough, my expectations were unfounded. How could he possibly sell this patent?"

"I'm lucky enough to have found a special medicine for liver cancer. I don't expect such a lucky thing to happen again."

Anna looked at Chen Xuan from the audience, her expression looking a bit tearful.

At this point, she had completely given up the idea of ​​finding a specific drug for lung cancer.

That’s right, she came here specifically to attend the event today, and she also represents Novartis’ attitude.

Novartis and Aetna Pharmaceuticals Group have cooperated, and Novartis will be the agent for the overseas sales of lung cancer drugs in the future, so it is natural for them to participate in this event.

At the same time, she also wanted to learn about the specific drugs for lung cancer to see if there was any chance to acquire them.

She didn't dare to spend 1000 billion to acquire the previous lung cancer drug because the risk was too high, but now there is no risk.

This made Anna feel that she could give it a try, and maybe there was really a chance of acquiring it.

But after hearing what Chen Xuan said, she knew it was impossible. No pharmaceutical company would buy it, and he didn't want to transfer the patent at all.

$1000 billion is enough to deter Novartis.

This accounts for almost half of Novartis's market value. How could they possibly come up with such a large sum of money?

Moreover, even if it is possible to take out the funds, it is impossible to invest so much money in one project. The risk factor is too high.

Even if this project will eventually succeed, it will take too long and Novartis may collapse at any time. This is not a wise investment.

Because of this, Anna gave up the idea and no longer hoped to acquire the specific drug for lung cancer.

At the same time, she was also very grateful that she was lucky enough to obtain a patent for a special liver cancer drug, which was indeed a great bargain.

Although the rights of liver cancer drugs are not as great as those of lung cancer drugs, and their indications are not as numerous, it is impossible for them to create such a miraculous disappearance myth.

However, as an anti-cancer drug, the market value of liver cancer specific drugs is still very high.

Being able to acquire it for 50 billion yuan can indeed be considered a bargain, but you won't be so lucky every time.

It is precisely because Anna understands this that she feels that she has found a bargain and is grateful for it.

However, Chen Xuan did not lose out. If he had not directly sold the formula of the liver cancer medicine, he would not have been able to obtain such a large amount of funds so quickly.

Sometimes, one-click buying and selling cannot fully consider the current benefits. The indirectly generated benefits may be directly far greater than the transaction amount of this transaction.

If Chen Xuan had kept the special medicine for liver cancer, he might still be conducting clinical trials now, and he would not have so much funds to push it to market, let alone the special medicine for lung cancer.

Therefore, only after he directly sold the special medicine for liver cancer could he take a shortcut.

This kind of transaction is a win-win situation, and there is no question of loss or gain. Both parties have gained very satisfactory results.

at this time,

There are many people who share the same idea as Anna.

Many pharmaceutical companies sent representatives to attend today's meeting.

Their purpose, of course, is not to watch the fun, but to find out if there is any opportunity.